Stock Analysis
- New Zealand
- /
- Healthcare Services
- /
- NZSE:MEE
Me Today Full Year 2023 Earnings: NZ$0.009 loss per share (vs NZ$0.024 loss in FY 2022)
Me Today (NZSE:MEE) Full Year 2023 Results
Key Financial Results
- Revenue: NZ$7.88m (up 19% from FY 2022).
- Net loss: NZ$13.0m (loss narrowed by 17% from FY 2022).
- NZ$0.009 loss per share (improved from NZ$0.024 loss in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Me Today shares are down 20% from a week ago.
Risk Analysis
It is worth noting though that we have found 5 warning signs for Me Today (4 are significant!) that you need to take into consideration.
Valuation is complex, but we're helping make it simple.
Find out whether Me Today is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NZSE:MEE
Me Today
Through its subsidiaries, produces, sells, and markets health and wellbeing products in New Zealand.
Medium with adequate balance sheet.